$OMEX
ODYSSEY MARINE EXPLORATION INC

2020 Q4 Form 10-K Financial Statement

#000119312521101428 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $301.3K $211.5K $520.0K
YoY Change -59.36% -72.25% -32.86%
Cost Of Revenue
YoY Change
Gross Profit $301.3K $211.5K $520.0K
YoY Change -59.36% -72.25% -32.86%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $1.360M $23.35K $1.283M
YoY Change -53.58% -98.89% -17.76%
% of Gross Profit 451.36% 11.04% 246.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $10.00K $0.00
YoY Change -100.0% -100.0%
% of Gross Profit 0.0% 4.73% 0.0%
Operating Expenses $1.360M $23.35K $1.283M
YoY Change -53.58% -98.89% -17.76%
Operating Profit -$1.059M -$4.680M -$4.047M
YoY Change -51.63% 34.85% 64.86%
Interest Expense -$2.210M $1.858M $1.562M
YoY Change 61.31% -9.34% 20.24%
% of Operating Profit
Other Income/Expense, Net -$80.00K -$2.897M -$1.775M
YoY Change -500.0% 21.97% 37.64%
Pretax Income -$3.350M -$7.577M -$5.823M
YoY Change -5.37% 29.62% 55.49%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.368M -$5.448M -$4.099M
YoY Change 4.39% 28.8% 47.74%
Net Earnings / Revenue -785.73% -2575.45% -788.24%
Basic Earnings Per Share -$0.51 -$0.43
Diluted Earnings Per Share -$190.1K -$0.51 -$0.43
COMMON SHARES
Basic Shares Outstanding 12.21M 10.62M 9.542M
Diluted Shares Outstanding 10.62M 9.542M

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.160M $9.110M $220.0K
YoY Change 2980.0% 2936.67% -40.54%
Cash & Equivalents $6.163M $9.108M $223.7K
Short-Term Investments
Other Short-Term Assets $587.4K $222.9K $322.8K
YoY Change -0.41% -27.45% 13.14%
Inventory
Prepaid Expenses $582.3K
Receivables $160.3K $46.71K $791.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.911M $9.377M $1.338M
YoY Change 464.23% 913.34% 6.63%
LONG-TERM ASSETS
Property, Plant & Equipment $614.8K $651.2K $687.0K
YoY Change -18.77% 10.29% 2862.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.370M $2.150M $1.500M
YoY Change 58.0% 52.48% 26.05%
Other Assets $41.81K $41.81K $26.81K
YoY Change 55.96% 55.96% 6.97%
Total Long-Term Assets $4.849M $4.668M $4.035M
YoY Change 18.12% 21.16% 224.9%
TOTAL ASSETS
Total Short-Term Assets $6.911M $9.377M $1.338M
Total Long-Term Assets $4.849M $4.668M $4.035M
Total Assets $11.76M $14.05M $5.373M
YoY Change 120.64% 193.93% 115.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.464M $8.236M $6.925M
YoY Change -76.54% 69.49% 69.6%
Accrued Expenses $18.97M $17.91M $17.41M
YoY Change 41.34% 34.56% 48.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $30.62M $32.06M $32.59M
YoY Change -2.64% 4.57% 10.96%
Total Short-Term Liabilities $53.88M $58.20M $56.93M
YoY Change 5.18% 19.2% 25.97%
LONG-TERM LIABILITIES
Long-Term Debt $11.49M $8.120M $5.960M
YoY Change 288.18% 475.89% 727.78%
Other Long-Term Liabilities $4.300M $4.340M $4.370M
YoY Change -3.15% 0.93% 14.4%
Total Long-Term Liabilities $15.79M $12.45M $10.34M
YoY Change 113.42% 118.06% 127.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.88M $58.20M $56.93M
Total Long-Term Liabilities $15.79M $12.45M $10.34M
Total Liabilities $69.67M $70.66M $67.27M
YoY Change 18.84% 29.56% 35.26%
SHAREHOLDERS EQUITY
Retained Earnings -$265.1M -$262.8M -$257.3M
YoY Change 5.92% 5.93% 5.53%
Common Stock $237.5M $235.5M $222.6M
YoY Change 7.46% 6.53% 2.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$27.63M -$27.31M -$34.72M
YoY Change
Total Liabilities & Shareholders Equity $11.76M $14.05M $5.373M
YoY Change 120.64% 193.93% 115.23%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$2.368M -$5.448M -$4.099M
YoY Change 4.39% 28.8% 47.74%
Depreciation, Depletion And Amortization $0.00 $10.00K $0.00
YoY Change -100.0% -100.0%
Cash From Operating Activities -$3.770M -$2.920M -$1.090M
YoY Change 110.61% 100.0% 49.32%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.20M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 820.0K 11.81M 880.0K
YoY Change -51.76% 749.64% -900.0%
NET CHANGE
Cash From Operating Activities -3.770M -2.920M -1.090M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 820.0K 11.81M 880.0K
Net Change In Cash -2.950M 8.890M -210.0K
YoY Change 3177.78% -12800.0% -75.58%
FREE CASH FLOW
Cash From Operating Activities -$3.770M -$2.920M -$1.090M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$3.770M -$2.920M -$1.090M
YoY Change 110.61% 100.0% 53.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6163205
CY2020Q4 us-gaap Assets Current
AssetsCurrent
6910856
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1224822
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7295717
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10664948
CY2020Q4 omex Property Plant And Equipment Subject To Operating Leases
PropertyPlantAndEquipmentSubjectToOperatingLeases
607039
CY2019Q4 omex Property Plant And Equipment Subject To Operating Leases
PropertyPlantAndEquipmentSubjectToOperatingLeases
739803
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7287999
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10647910
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
2370794
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1500000
CY2020Q4 omex Exploration License
ExplorationLicense
1821251
CY2019Q4 omex Exploration License
ExplorationLicense
1821251
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41806
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26806
CY2020Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
4233851
CY2019Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
3348057
CY2020Q4 us-gaap Assets
Assets
11759464
CY2019Q4 us-gaap Assets
Assets
5329720
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4149747
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6237987
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
18971936
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
13422715
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
142080
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
123152
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
30620230
CY2019Q4 us-gaap Loans Payable Current
LoansPayableCurrent
31446389
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
53883993
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
51230243
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
11489029
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
2957097
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
478966
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
621046
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
15786745
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7396893
CY2020Q4 us-gaap Liabilities
Liabilities
69670738
CY2019Q4 us-gaap Liabilities
Liabilities
58627136
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
237505357
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
221027057
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-265134463
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-250322307
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-27627847
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-29294302
CY2020 omex Operations And Research Expense
OperationsAndResearchExpense
10923819
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
13419680
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-30283427
CY2019Q4 us-gaap Minority Interest
MinorityInterest
-24003114
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-57911274
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-53297416
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11759464
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5329720
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2038332
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3072987
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3275753
CY2019 omex Operations And Research Expense
OperationsAndResearchExpense
7927831
CY2018 omex Operations And Research Expense
OperationsAndResearchExpense
3688560
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3749912
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5491849
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5654409
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
14673731
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
9342969
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-12635399
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-10346693
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-6067216
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
5121
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
151
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
56408
CY2020 us-gaap Interest Expense
InterestExpense
6915535
CY2019 us-gaap Interest Expense
InterestExpense
5360192
CY2018 us-gaap Interest Expense
InterestExpense
3142280
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-777484
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-290024
CY2020 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-732958
CY2019 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-322485
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-36214
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
819517
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48803
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8457070
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5153033
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3037069
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-21092469
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15499726
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9104285
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6280313
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5059765
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3931849
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.41
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.12
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10538114
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9346213
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8583795
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-41196537
CY2020 us-gaap Profit Loss
ProfitLoss
-21092469
CY2018 us-gaap Depreciation
Depreciation
453466
CY2019 omex Debt Modification Inducement
DebtModificationInducement
-868878
CY2019 us-gaap Profit Loss
ProfitLoss
-15499726
CY2018 us-gaap Profit Loss
ProfitLoss
-9104285
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-150322
CY2019 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
845892
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
111180
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
192532
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
55200
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
278947
CY2020 us-gaap Depreciation
Depreciation
9322
CY2019 us-gaap Depreciation
Depreciation
116434
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-777484
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-290024
CY2019 omex Director Fees Settled With Equity Instruments
DirectorFeesSettledWithEquityInstruments
701396
CY2020 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-732958
CY2019 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-322485
CY2020 omex Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
132764
CY2019 omex Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
53233
CY2020 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
52213
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
870794
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
747333
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
752667
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
897664
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
825000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-261336
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-367828
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
578156
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-399082
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-355126
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-11891
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4563544
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3690481
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
496068
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5583783
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3960783
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3528805
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9287169
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5444299
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6452415
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1003662
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15492
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9624
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15492
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
994038
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3620977
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3271181
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1925000
CY2018 omex Payments For Proceeds From Restricted Cash Held As Collateral
PaymentsForProceedsFromRestrictedCashHeldAsCollateral
125
CY2018 omex Settlement Receipts From Contractual Obligations
SettlementReceiptsFromContractualObligations
15000000
CY2018 omex Payment Of Contractual Obligations
PaymentOfContractualObligations
14000000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4561739
CY2020 omex Payment Of Operating Lease Liability
PaymentOfOperatingLeaseLiability
123152
CY2019 omex Payment Of Operating Lease Liability
PaymentOfOperatingLeaseLiability
48838
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
286198
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
346130
CY2018 us-gaap Repayments Of Debt
RepaymentsOfDebt
349598
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15236985
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2876213
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7137016
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5949816
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2583578
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1678639
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213389
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2796967
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1118328
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6163205
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1275269
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1544663
CY2018 us-gaap Interest Paid Net
InterestPaidNet
1247337
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10538114
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9346213
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8583795
CY2020 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
5.06
CY2019 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
4.93
CY2018 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
6.81
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1112293
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1112293
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-14812156
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-10439961
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-5172436
CY2020 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-14812156
CY2019 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-10439961
CY2018 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-5172436
CY2020 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
10538114
CY2019 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
9346213
CY2018 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
8583795
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
861484
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
160257
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
421593
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
582319
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
584765
CY2020Q4 us-gaap Security Deposit
SecurityDeposit
CY2020Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
5075
CY2019Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
5075
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
587394
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
589840
CY2020Q4 omex Property Plant And Equipment Gross Including Right Of Use Asset
PropertyPlantAndEquipmentGrossIncludingRightOfUseAsset
7902756
CY2019Q4 omex Property Plant And Equipment Gross Including Right Of Use Asset
PropertyPlantAndEquipmentGrossIncludingRightOfUseAsset
11404751
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
614757
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
756841
CY2020Q4 us-gaap Loans Payable
LoansPayable
42109259
CY2019Q4 us-gaap Loans Payable
LoansPayable
34403486
CY2016Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
3000000
CY2020Q4 omex Fair Value Reacquisition Price
FairValueReacquisitionPrice
1340024
CY2020 omex Debt Modification Inducement
DebtModificationInducement
-868878
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 omex Earnest Money Deposit
EarnestMoneyDeposit
-450000
CY2019Q4 omex Earnest Money Deposit
EarnestMoneyDeposit
-450000
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
221504
CY2020Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
355814
CY2019Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
9494391
CY2020Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
15800317
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
422130
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
243995
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2821349
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1136754
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13422715
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18971936
CY2019Q4 omex Accrued Other Operating Expenses Current
AccruedOtherOperatingExpensesCurrent
13341
CY2020Q4 omex Accrued Other Operating Expenses Current
AccruedOtherOperatingExpensesCurrent
985056
CY2019Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
300000
CY2020Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
800000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3818750
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3818750
CY2020Q4 omex Revenue Participation Agreement Value
RevenueParticipationAgreementValue
15000000
CY2020Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2553314
CY2020Q3 omex Purchase Price Of Warrant
PurchasePriceOfWarrant
4.543
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.75
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
420648
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
756596
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
415615
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.95
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
238651
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.95
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
238651
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.95
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.95
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
238651
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.95
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
238651
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.95
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
238651
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
238651
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
36.52
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9166
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.76
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
247817
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
98129
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15564
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15564
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
98129
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15564
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15564
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
231952
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
238651
CY2020 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y10M2D
CY2020Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
15.95
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020Q4 omex Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards
DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwards
66867637
CY2020Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
5683
CY2020Q4 omex Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpenses
253374
CY2020Q4 omex Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
5837
CY2020Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
394649
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1464210
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
68859984
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
191340
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
48545
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
142795
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
191340
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
68859984
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
56819522
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
12040462
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4429419
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3254942
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1923757
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-940302
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-156858
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-92707
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
150238
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
262776
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
29670
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4815784
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5170161
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-2021137
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3765560
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-2514825
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1778766
CY2020Q4 omex Working Capital Deficit
WorkingCapitalDeficit
47000000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
447702
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
458325
CY2020Q4 omex Percentage Of Annual Rent Accretion In Operating Lease
PercentageOfAnnualRentAccretionInOperatingLease
0.03
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
147539
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
151965
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
156524
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
548912
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
92884
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
700000
CY2020Q4 us-gaap Accounts Payable Interest Bearing Interest Rate
AccountsPayableInterestBearingInterestRate
0.12
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1005511
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
519969
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
211538
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
301314
CY2020Q1 us-gaap Gross Profit
GrossProfit
1005511
CY2020Q2 us-gaap Gross Profit
GrossProfit
519969
CY2020Q3 us-gaap Gross Profit
GrossProfit
211538
CY2020Q4 us-gaap Gross Profit
GrossProfit
301314
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2897976
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4098623
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-5448046
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-2367511
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
794927
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
774436
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
762175
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
741449
CY2019Q1 us-gaap Gross Profit
GrossProfit
794927
CY2019Q2 us-gaap Gross Profit
GrossProfit
774436
CY2019Q3 us-gaap Gross Profit
GrossProfit
762175
CY2019Q4 us-gaap Gross Profit
GrossProfit
741449
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1167886
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2774282
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-4229833
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-2267960
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Security12b Title
Security12bTitle
Common Stock
CY2020 dei Trading Symbol
TradingSymbol
OMEX
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q2 dei Entity Public Float
EntityPublicFloat
40800000
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12591084
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 omex Income Tax Reconciliation Debt Extinguishment
IncomeTaxReconciliationDebtExtinguishment
91266
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1259
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
948
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24984166
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2020 omex Income Tax Reconciliation Litigation Funding
IncomeTaxReconciliationLitigationFunding
2482252
CY2019Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24984166
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 dei Entity Registrant Name
EntityRegistrantName
ODYSSEY MARINE EXPLORATION INC
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000798528
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-31895
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12591084
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12591084
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9478009
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9478009
CY2020 us-gaap Accretion Expense
AccretionExpense
121398
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11315000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
89642
CY2020 omex Proceeds From Sale Of Equity Of Subsidiary
ProceedsFromSaleOfEquityOfSubsidiary
800000
CY2020 us-gaap Stock Issued1
StockIssued1
278602
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
50000
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1063811
CY2020Q4 omex Collateral Asset Carrying Value
CollateralAssetCarryingValue
0
CY2020 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
0
CY2019 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
0
CY2020 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
194000
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
171000
CY2019Q4 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
224916
CY2020Q4 omex Deferred Tax Assets Debt Extinguishment
DeferredTaxAssetsDebtExtinguishment
59934
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
300000
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11200000
CY2020 omex Income Tax Reconciliation Sub Part F Income
IncomeTaxReconciliationSubPartFIncome
345006
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div><div style="text-indent: 9%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management uses estimates and assumptions in preparing these consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1901989
CY2020 omex Short Term Investments Maturity Period
ShortTermInvestmentsMaturityPeriod
P3M
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3481314
CY2020Q4 omex Accrued Other Operating Expenses For Exploration Permit Current
AccruedOtherOperatingExpensesForExplorationPermitCurrent
900000
CY2020Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.6
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
981783
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
490000
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
2084442
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
732958
CY2020 us-gaap Debt Conversion Description
DebtConversionDescription
Applicable Conversion Amount&#8221; means, on the date of determination and with respect to each Note, (a) for the period beginning on the date of issuance and ending on the day immediately preceding the Maturity Date, an amount equal to 100.0% of the amount of the Loan evidenced by such Note then outstanding; (b) on the Maturity Date, 136.0% of the amount of the Loan evidenced by such Note then outstanding (such amount, the &#8220;Enhanced Conversion Amount&#8221;); (c) for the period beginning on the day immediately following the Maturity Date and for a period of three months thereafter (such three-month period, the &#8220;Accrual Period&#8221;), an amount equal to (i) the Enhanced Conversion Amount then outstanding plus (ii) an additional amount equal to 3.0% per month (prorated for any period of less than a full month) accrued on the amount described in clause (i); and (d) on any date after the Accrual Period, the amount then outstanding after giving effect to the accrual described in clause (c) during the Accrual Period (it being understood that no additional amount shall accrue after the expiration of the Accrual Period); and &#8220;Applicable Conversion Rate&#8221; means (x) with respect to any conversion on or prior to the Maturity Date, $5.00, and (y) with respect to any conversion after the Maturity Date, the lower of (i) $5.00 and (ii) 80.0% of the ten-day volume-weighted average price of Odyssey&#8217;s common stock. Notwithstanding anything in the Purchase Agreement to the contrary, we are prohibited from issuing any Conversion Shares, to the extent such shares, after giving effect to such issuance after conversion and when added to the number of Conversion Shares previously issued upon conversion of any of the Notes sold pursuant to the Purchase Agreement, would represent in excess of 19.9% of (A) the number of shares of our common stock outstanding immediately after giving effect to such issuances or (B) the total voting power of our securities outstanding immediately after giving effect to such issuances that are entitled to vote on a matter being voted on by holders of our common stock.
CY2020 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
329498
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
290024
CY2020Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
358497
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
323171
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
129487
CY2020Q4 omex Amount With Held To Pay The Offering Costs At A Later Date
AmountWithHeldToPayTheOfferingCostsAtALaterDate
200000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213389
CY2020 omex Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
3
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2015-08-31
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2020 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
CY2019 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
CY2018 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
CY2020Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
0
CY2019Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
0
CY2018Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
0
CY2020 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
20
CY2020Q3 omex Offering Fee Included In Offering Expenses
OfferingFeeIncludedInOfferingExpenses
200000

Files In Submission

Name View Source Status
0001193125-21-101428-index-headers.html Edgar Link pending
0001193125-21-101428-index.html Edgar Link pending
0001193125-21-101428.txt Edgar Link pending
0001193125-21-101428-xbrl.zip Edgar Link pending
d96991d10k.htm Edgar Link pending
d96991dex211.htm Edgar Link pending
d96991dex231.htm Edgar Link pending
d96991dex232.htm Edgar Link pending
d96991dex311.htm Edgar Link pending
d96991dex312.htm Edgar Link pending
d96991dex321.htm Edgar Link pending
d96991dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g96991dsp3newodyssey.jpg Edgar Link pending
g96991ex231header.jpg Edgar Link pending
g96991ex231sig.jpg Edgar Link pending
g96991ex232logov1.jpg Edgar Link pending
omex-20201231.xml Edgar Link completed
omex-20201231.xsd Edgar Link pending
omex-20201231_cal.xml Edgar Link unprocessable
omex-20201231_def.xml Edgar Link unprocessable
omex-20201231_lab.xml Edgar Link unprocessable
omex-20201231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending